|
1
|
Elmore SA, Jones JL, Conrad PA, Patton S,
Lindsay DS and Dubey JP: Toxoplasma gondii: Epidemiology, feline
clinical aspects, and prevention. Trends Parasitol. 26:190–196.
2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mcleod R, Van Tubbergen C, Montoya J and
Petersen E: Human toxoplasma infection. In: Toxoplasma Gondii: The
Model Apicomplexan-Perspectives and Methods. Elsevier, Amsterdam,
2013.
|
|
3
|
Sasai M and Yamamoto M: Innate, adaptive,
and cell-autonomous immunity against Toxoplasma gondii infection.
Exp Mol Med. 51:1–10. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kato S, Chmielewski M, Honda H,
Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P and
Lindholm B: Aspects of immune dysfunction in end-stage renal
disease. Clin J Am Soc Nephrol. 3:1526–1533. 2008.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Omrani VF, Fallahi S, Rostami A,
Siyadatpanah A, Barzgarpour G, Mehravar S, Memari F, Hajialiani F
and Joneidi Z: Prevalence of intestinal parasite infections and
associated clinical symptoms among patients with end-stage renal
disease undergoing hemodialysis. Infection. 43:537–544.
2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tamura MK: Incidence, management, and
outcomes of end-stage renal disease in the elderly. Curr Opin
Nephrol Hypertens. 18:252–257. 2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
West AP, Koblansky AA and Ghosh S:
Recognition and signaling by toll-like receptors. Annu Rev Cell Dev
Biol. 22:409–437. 2006.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gonzalez RMS, Shehata H, O'connell MJ,
Yang Y, Moreno-Fernandez ME, Chougnet CA and Aliberti J: Toxoplasma
gondii-derived profilin triggers human toll-like receptor
5-dependent cytokine production. J Innate Immun. 6:685–694.
2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zeng HM, Pan KF, Zhang Y, Zhang L, Ma JL,
Zhou T, Su HJ, Li WQ, LI JY, Gerhard M, et al: Genetic variants of
toll-like receptor 2 and 5, helicobacter pylori infection, and risk
of gastric cancer and its precursors in a Chinese population.
Cancer Epidemiol Biomarkers Prev. 20:2594–2602. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Seok H, Lee BC, Kim YO and Chung JH:
Association between Exonic SNPs of TLR5 and Benign Prostate
Hyperplasia in Korean Population. Korean J Str Res. 21:331–337.
2013.
|
|
11
|
Rutkowski MR, Stephen TL, Svoronos N,
Allegrezza MJ, Tesone AJ, Perales-Puchalt A, Brencicova E,
Escovar-Fadul X, Nguyen JM, Cadungog MG, et al: Microbially driven
TLR5-dependent signaling governs distal malignant progression
through tumor-promoting inflammation. Cancer Cell. 27:27–40.
2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ghasemali S, Nejati-Koshki K, Tafsiri E,
Rahmati-Yamchi M, Akbarzadeh A, Alizadeh E, Abbasi M, Barkhordari
A, Tozihi M, Kordi S and Zarghami N: Inhibitory effects of
beta-cyclodextrin-helenalin complexes on H-TERT gene expression in
the T47D breast cancer cell line-results of real time quantitative
PCR. Asian Pac J Cancer Prev. 14:6949–6953. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Jha V, Al-Ghamdi SMG, Li G, Wu MS,
Stafylas P, Retat L, Card-Gowers J, Barone S, Cabrera C and Sanchez
JJ: Global economic burden associated with chronic kidney disease:
A pragmatic review of medical costs for the Inside CKD research
programme. Adv Ther. 40:4405–4420. 2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Robert F and Pelletier J: Exploring the
impact of single-nucleotide polymorphisms on translation. Front
Genet. 9(507)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Shuang C, Weiguang Y, Zhenkun F, Yike H,
Jiankun Y, Jing X, Xinghan L, Yue L and Dalin L: Toll-like receptor
5 gene polymorphism is associated with breast cancer
susceptibility. Oncotarget. 8:88622–88629. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Chaichana P, Chantratita N, Brod F,
Koosakulnirand S, Jenjaroen K, Chumseng S, Sumonwiriya M, Burtnick
MN, Brett PJ, Teparrukkul P, et al: A nonsense mutation in TLR5 is
associated with survival and reduced IL-10 and TNF-α levels in
human melioidosis. PLoS Negl Trop Dis. 11(e0005587)2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hawn TR, Verbon A, Lettinga KD, Zhao LP,
LI SS, Laws RJ, Skerrett SJ, Beutler B, Schroeder L, Nachman A, et
al: A common dominant TLR5 stop codon polymorphism abolishes
flagellin signaling and is associated with susceptibility to
legionnaires' disease. J Exp Med. 198:1563–1572. 2003.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Meena NK, Ahuja V, Meena K and Paul J:
Association of TLR5 gene polymorphisms in ulcerative colitis
patients of North India and their role in cytokine homeostasis.
PLoS One. 10(e0120697)2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Klimosch SN, Foersti A, Eckert J, Knežević
J, Bevier M, von Schoenfels W, Heits N, Walter J, Hinz S, Lascorz
J, et al: Functional TLR5 genetic variants affect human colorectal
cancer SurvivalTLR variants affect colorectal cancer survival.
Cancer Res. 73:7232–7242. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Xiao W and Liu Z, Lin J, Xiong C, Li J, Wu
K, Ma Y, Gong Y and Liu Z: Association of TLR4 and TLR5 gene
polymorphisms with Graves' disease in Chinese Cantonese population.
Hum Immunol. 75:609–613. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Cao L, Zhang T, Zhu J, Li A, Zheng K,
Zhang N, Su B, Xia W, Wu H, Li N and He Q: Polymorphism of TLR 5
rs5744174 is associated with disease progression in Chinese
patients with chronic HBV infection. APMIS. 125:708–716.
2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Gharadaghi Y, Shojaee S, Khaki A,
Fathiazad F, Khaki AA, Ghdamkheir E and Rouhaninia M: Antiprotozoal
effect of Allium cepa on acute renal failure caused by Toxoplasma
gondii. Afr J Pharm Pharmacol. 6:771–777. 2012.
|
|
24
|
Dabagh-Gorjani F, Anvari F, Zolghadri J,
Kamali-Sarvestani E and Gharesi-Fard B: Differences in the
expression of TLRs and inflammatory cytokines in pre-eclamptic
compared with healthy pregnant women. Iran J Immunol. 11:233–245.
2014.PubMed/NCBI
|
|
25
|
Tbahriti HF, Meknassi D, Moussaoui R,
Messaoudi A, Zemour L, Kaddous A, Bouchenak M and Mekki K:
Inflammatory status in chronic renal failure: The role of
homocysteinemia and pro-inflammatory cytokines. World J Nephrol.
2:31–37. 2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhao XY and Ewald SE: The molecular
biology and immune control of chronic Toxoplasma gondii infection.
J Clin Invest. 130:3370–3380. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Meira CS, Pereira-Chioccola VL, Vidal JE,
de Mattos CCB, Motoie G, Costa-Silva TA, Gava R, Frederico FB, de
Mattos LC and Groups T: Cerebral and ocular toxoplasmosis related
with IFN-γ, TNF-α, and IL-10 levels. Front Microbiol.
5(492)2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Salem MS, Shaker MJ and Mohammed NK:
Impact of toxoplasmosis in im-mune respons in hemodialysis
patients. Diyala J Medicine. 22:1–11. 2022.
|
